Home › Funds › SUMITOMO MITSUI FINANCIAL GROUP, INC. › BSX

SUMITOMO MITSUI FINANCIAL GROUP, INC. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

SUMITOMO MITSUI FINANCIAL GROUP, INC. reported holding 474,844 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$20.7M, representing 0.44% of its reported portfolio and ranking #32 among its reported holdings. SUMITOMO MITSUI FINANCIAL GROUP, INC. has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)474.84K sh
Reported value held$20.73M
Portfolio Weight0.44%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SUMITOMO MITSUI FINANCIAL GROUP, INC.'s BSX position evolved

SUMITOMO MITSUI FINANCIAL GROUP, INC. first disclosed a stake in BSX in Q4 2024 at 150,810 shares (US$13.5M). The position peaked in Q3 2025 at 265,781 shares, worth US$25.9M. Across 8 filings, SUMITOMO MITSUI FINANCIAL GROUP, INC. increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 474,844 shares valued at US$20.7M — an increase of 62,312 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 150.81K $13.47M New
Q1 2025 205.64K $20.75M Add
Q2 2025 235.48K $25.29M Add
Q3 2025 265.78K $25.95M Add
Q4 2025 269.88K $25.73M Add
Q1 2026 334.76K $21.01M Add
Q2 2026 412.53K $17.61M Add
Q3 2026 474.84K $20.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has SUMITOMO MITSUI FINANCIAL GROUP, INC. held BSX?

SUMITOMO MITSUI FINANCIAL GROUP, INC. has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is SUMITOMO MITSUI FINANCIAL GROUP, INC.'s current position in BSX?

As of Q3 2026, SUMITOMO MITSUI FINANCIAL GROUP, INC. holds 474.84K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $20.73M, representing 0.44% of its reported portfolio and ranking #32.

Has SUMITOMO MITSUI FINANCIAL GROUP, INC. been buying or selling BSX?

In the latest 13F filing (Q3 2026), SUMITOMO MITSUI FINANCIAL GROUP, INC. increased its position in BSX. The position peaked in Q3 2025 at 265.78K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.